Published in Emerg Infect Dis on May 01, 2015
Public health and international drug policy. Lancet (2016) 1.71
A method for near full-length amplification and sequencing for six hepatitis C virus genotypes. BMC Genomics (2016) 0.86
The Prison Economy of Needles and Syringes: What Opportunities Exist for Blood Borne Virus Risk Reduction When Prices Are so High? PLoS One (2016) 0.75
Unlocking dimensions of social capital in the prison setting. Health Justice (2016) 0.75
The Prevalence of Hepatitis B and C Among Prisoners in Kahramanmaras, Turkey. Jundishapur J Microbiol (2016) 0.75
Incident Hepatitis C Virus Genotype Distribution and Multiple Infection in Australian Prisons. J Clin Microbiol (2016) 0.75
A molecular transmission network of recent hepatitis C infection in people with and without HIV: Implications for targeted treatment strategies. J Viral Hepat (2016) 0.75
Phylogenetic analysis of full-length, early infection, hepatitis C virus genomes among people with intravenous drug use: the InC(3) Study. J Viral Hepat (2016) 0.75
MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol (2011) 220.97
A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol (2003) 102.57
jModelTest 2: more models, new heuristics and parallel computing. Nat Methods (2012) 27.83
Global epidemiology of hepatitis C virus infection. Lancet Infect Dis (2005) 16.44
Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology (2005) 9.39
The health of prisoners. Lancet (2010) 8.21
Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology (2014) 4.15
Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis. Hepatology (2013) 3.54
The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. Addiction (2011) 2.95
Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews. Addiction (2010) 2.59
Global control of hepatitis C: where challenge meets opportunity. Nat Med (2013) 2.22
Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection. PLoS Pathog (2011) 2.13
Frequent multiple hepatitis C virus infections among injection drug users in a prison setting. Hepatology (2010) 1.77
Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates. J Clin Microbiol (2007) 1.70
Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis. J Epidemiol Community Health (2008) 1.61
Genetic variation in interleukin 28B with respect to vertical transmission of hepatitis C virus and spontaneous clearance in HCV-infected children. Hepatology (2011) 1.57
Patterns and characteristics of hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian trial in acute hepatitis C. Clin Infect Dis (2011) 1.32
A novel methodology for large-scale phylogeny partition. Nat Commun (2011) 1.29
Transmission patterns of HIV and hepatitis C virus among networks of people who inject drugs. PLoS One (2011) 1.20
High-risk drug-use practices among a large sample of Australian prisoners. Drug Alcohol Depend (2012) 1.20
Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort. BMC Public Health (2010) 1.18
Incidence and risk for acute hepatitis C infection during imprisonment in Australia. Eur J Epidemiol (2010) 1.18
Viral hepatitis in incarcerated adults: a medical and public health concern. Am J Gastroenterol (2009) 1.17
The harm inside: injection during incarceration among male injection drug users in Tijuana, Mexico. Drug Alcohol Depend (2009) 1.16
Molecular epidemiology of hepatitis C virus in a social network of injection drug users. J Infect Dis (2004) 1.11
Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots. J Viral Hepat (2011) 1.07
Hepatitis C virus phylogenetic clustering is associated with the social-injecting network in a cohort of people who inject drugs. PLoS One (2012) 1.07
Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: the HITS-c study. Med J Aust (2014) 0.99
A prospective study of hepatitis C incidence in Australian prisoners. Addiction (2014) 0.99
Hepatitis C worldwide and in Brazil: silent epidemic--data on disease including incidence, transmission, prevention, and treatment. ScientificWorldJournal (2014) 0.94
Viral load in HCV RNA-positive pregnant women. Am J Gastroenterol (2001) 0.92
Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, Canada. Hepatology (2014) 0.91
A novel method to identify routes of hepatitis C virus transmission. PLoS One (2014) 0.85
Sequencing of the Hepatitis C Virus: A Systematic Review. PLoS One (2013) 0.83
Norovirus illness is a global problem: emergence and spread of norovirus GII.4 variants, 2001-2007. J Infect Dis (2009) 4.25
Proposal for a unified norovirus nomenclature and genotyping. Arch Virol (2013) 3.36
The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology (2013) 3.14
Emergence of a new norovirus genotype II.4 variant associated with global outbreaks of gastroenteritis. J Clin Microbiol (2006) 2.97
Rapid evolution of pandemic noroviruses of the GII.4 lineage. PLoS Pathog (2010) 2.80
Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection. Hepatology (2010) 2.56
Norovirus recombination in ORF1/ORF2 overlap. Emerg Infect Dis (2005) 2.41
Norovirus recombination. J Gen Virol (2007) 2.22
GemSIM: general, error-model based simulator of next-generation sequencing data. BMC Genomics (2012) 2.21
Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection. PLoS Pathog (2011) 2.13
Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation. J Leukoc Biol (2003) 2.13
Epidemics of gastroenteritis during 2006 were associated with the spread of norovirus GII.4 variants 2006a and 2006b. Clin Infect Dis (2008) 2.12
Detection of human sapovirus by real-time reverse transcription-polymerase chain reaction. J Med Virol (2006) 2.12
Evolution of AbaR-type genomic resistance islands in multiply antibiotic-resistant Acinetobacter baumannii. J Antimicrob Chemother (2010) 2.06
Effective treatment of injecting drug users with recently acquired hepatitis C virus infection. Gastroenterology (2009) 1.99
Recombination within the pandemic norovirus GII.4 lineage. J Virol (2013) 1.93
Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection. Hepatology (2013) 1.77
Frequent multiple hepatitis C virus infections among injection drug users in a prison setting. Hepatology (2010) 1.77
To exercise or not to exercise in chronic fatigue syndrome? No longer a question. Med J Aust (2004) 1.77
Cancer-related fatigue in women with breast cancer: outcomes of a 5-year prospective cohort study. J Clin Oncol (2012) 1.73
Mechanisms of GII.4 norovirus evolution. Trends Microbiol (2011) 1.72
DbPTM 3.0: an informative resource for investigating substrate site specificity and functional association of protein post-translational modifications. Nucleic Acids Res (2012) 1.71
Using approximate Bayesian computation to estimate tuberculosis transmission parameters from genotype data. Genetics (2006) 1.68
Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine. Lancet Infect Dis (2012) 1.66
Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort. J Infect Dis (2004) 1.54
Gene expression correlates of postinfective fatigue syndrome after infectious mononucleosis. J Infect Dis (2007) 1.44
Cohort profile: the international collaboration of incident HIV and hepatitis C in injecting cohorts (InC3) study. Int J Epidemiol (2012) 1.39
spolTools: online utilities for analyzing spoligotypes of the Mycobacterium tuberculosis complex. Bioinformatics (2008) 1.35
Contribution of intra- and interhost dynamics to norovirus evolution. J Virol (2011) 1.32
Norovirus GII.4 variant 2006b caused epidemics of acute gastroenteritis in Australia during 2007 and 2008. J Clin Virol (2010) 1.29
Genetic diversity of Sapovirus in children, Australia. Emerg Infect Dis (2006) 1.29
Norovirus excretion in an aged-care setting. J Clin Microbiol (2008) 1.27
Next generation deep sequencing and vaccine design: today and tomorrow. Trends Biotechnol (2012) 1.24
Epidemic strains of Shigella sonnei biotype g carrying integrons. J Clin Microbiol (2002) 1.22
Antibiotic resistance determinants in nosocomial strains of multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother (2008) 1.22
Epidemiological and clinical consequences of within-host evolution. Trends Microbiol (2010) 1.22
Cytokine polymorphisms have a synergistic effect on severity of the acute sickness response to infection. Clin Infect Dis (2008) 1.19
Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort. BMC Public Health (2010) 1.18
Incidence and risk for acute hepatitis C infection during imprisonment in Australia. Eur J Epidemiol (2010) 1.18
Prevalence of production of virus-specific interferon-gamma among seronegative hepatitis C-resistant subjects reporting injection drug use. J Infect Dis (2004) 1.14
Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirements. Clin Infect Dis (2013) 1.14
Quantification of hepatitis C virus in human liver and serum samples by using LightCycler reverse transcriptase PCR. J Clin Microbiol (2002) 1.14
PlantPhos: using maximal dependence decomposition to identify plant phosphorylation sites with substrate site specificity. BMC Bioinformatics (2011) 1.10
Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection. Hepatology (2012) 1.07
Differences in amniotic fluid and maternal serum cytokine levels in early midtrimester women without evidence of infection. Cytokine (2008) 1.05
Regulation of MMPs and TIMPs by IL-1beta during corneal ulceration and infection. Invest Ophthalmol Vis Sci (2003) 1.05
Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia. Blood (2013) 1.04
Clearance of hepatitis C virus after newly acquired infection in injection drug users. J Infect Dis (2004) 1.04
Risk factors for hepatitis C infection and perception of antibody status among male prison inmates in the Hepatitis C Incidence and Transmission in Prisons Study cohort, Australia. J Urban Health (2004) 1.03
Deep sequencing of evolving pathogen populations: applications, errors, and bioinformatic solutions. Microb Inform Exp (2014) 1.02
Multiplex PCR testing detection of higher-than-expected rates of cervical mycoplasma, ureaplasma, and trichomonas and viral agent infections in sexually active australian women. J Clin Microbiol (2009) 1.02
Exploiting maximal dependence decomposition to identify conserved motifs from a group of aligned signal sequences. Bioinformatics (2011) 1.00
In vitro assessment of the further potential for development of fluoroquinolone resistance in Neisseria meningitidis. Antimicrob Agents Chemother (2005) 0.99
A prospective study of hepatitis C incidence in Australian prisoners. Addiction (2014) 0.99
Establishment of a successful assessment and treatment service for Australian prison inmates with chronic hepatitis C. Med J Aust (2010) 0.98
Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users. J Hepatol (2010) 0.98
The aadB gene cassette is associated with blaSHV genes in Klebsiella species producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother (2005) 0.97
Accurate single nucleotide variant detection in viral populations by combining probabilistic clustering with a statistical test of strand bias. BMC Genomics (2013) 0.96
Cutting edge: vasoactive intestinal peptide acts as a potent suppressor of inflammation in vivo by trans-deactivating chemokine receptors. J Immunol (2003) 0.95
Multidrug-resistant Salmonella strains expressing emerging antibiotic resistance determinants. Clin Infect Dis (2008) 0.95
Postinfective fatigue syndrome is not associated with altered cytokine production. Clin Infect Dis (2007) 0.94
Modeling the in vitro 20S proteasome activity: the effect of PA28-alphabeta and of the sequence and length of polypeptides on the degradation kinetics. J Mol Biol (2008) 0.94
Cytomegalovirus infection during pregnancy with maternofetal transmission induces a proinflammatory cytokine bias in placenta and amniotic fluid. J Infect Dis (2012) 0.93
Polymerase chain reaction screening for integrons can be used to complement resistance surveillance programs. Commun Dis Intell Q Rep (2003) 0.92
HIV and co-infections. Immunol Rev (2013) 0.92
Carboxylator: incorporating solvent-accessible surface area for identifying protein carboxylation sites. J Comput Aided Mol Des (2011) 0.91
Protective immunity against hepatitis C virus infection. Immunol Cell Biol (2006) 0.91
The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infection. J Hepatol (2003) 0.90
Effects and interactions in an environmentally relevant mixture of pharmaceuticals. Toxicol Sci (2007) 0.90
Naturally occurring dominant drug resistance mutations occur infrequently in the setting of recently acquired hepatitis C. Antivir Ther (2014) 0.89
Comparison of the replication properties of murine and human calicivirus RNA-dependent RNA polymerases. Virus Genes (2010) 0.89
Eotaxin expression by epithelial cells and plasma cells in chronic asthma. Lab Invest (2002) 0.89
A novel assay for detection of hepatitis C virus-specific effector CD4(+) T cells via co-expression of CD25 and CD134. J Immunol Methods (2011) 0.89
High-affinity aptamers to subtype 3a hepatitis C virus polymerase display genotypic specificity. Antimicrob Agents Chemother (2006) 0.88
Hepatitis C virus nonstructural protein 5B is involved in virus morphogenesis. J Virol (2012) 0.87
Enhancing assessment and treatment of hepatitis C in the custodial setting. Clin Infect Dis (2013) 0.87
Effect of pegylated interferon-α-2a treatment on mental health during recent hepatitis C virus infection. J Gastroenterol Hepatol (2012) 0.86
Positioning of leukocyte subsets in the portal and lobular compartments of hepatitis C virus-infected liver correlates with local chemokine expression. J Gastroenterol Hepatol (2014) 0.86
Incorporating evolutionary information and functional domains for identifying RNA splicing factors in humans. PLoS One (2011) 0.86
Chloramphenicol-resistant Neisseria meningitidis containing catP isolated in Australia. J Antimicrob Chemother (2003) 0.86
Are common childhood or adolescent infections risk factors for schizophrenia and other psychotic disorders? Med J Aust (2009) 0.85
If I am in the mood, I enjoy it: an exploration of cancer-related fatigue and sexual functioning in women with breast cancer. Oncologist (2011) 0.85
Virological responses during treatment for recent hepatitis C virus: potential benefit for ribavirin use in HCV/HIV co-infection. AIDS (2012) 0.84
Acquiring hepatitis C in prison: the social organisation of injecting risk. Harm Reduct J (2015) 0.84
A fluorescence-based high-throughput screen to identify small compound inhibitors of the genotype 3a hepatitis C virus RNA polymerase. J Biomol Screen (2013) 0.84
Impaired hepatitis C virus (HCV)-specific interferon-γ responses in individuals with HIV who acquire HCV infection: correlation with CD4(+) T-cell counts. J Infect Dis (2012) 0.83
A two-layered machine learning method to identify protein O-GlcNAcylation sites with O-GlcNAc transferase substrate motifs. BMC Bioinformatics (2015) 0.82